COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment.

IF 1.5 4区医学 Q3 PSYCHIATRY

Annals of Clinical Psychiatry Pub Date : 2023-05-01 DOI:10.12788/acp.0109

Joan Oh, Puneet Chawla Sahota, Tarannum Mohammadi, Basant K Pradhan, Maju Mathew Koola

{"title":"COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment.","authors":"Joan Oh, Puneet Chawla Sahota, Tarannum Mohammadi, Basant K Pradhan, Maju Mathew Koola","doi":"10.12788/acp.0109","DOIUrl":null,"url":null,"abstract":"Background: Emerging literature supports the association between acute COVID-19 infection and neuropsychiatric complications. This article reviews the evidence for catatonia as a potential neuropsychiatric sequela of COVID-19 infection.Methods: PubMed was searched using the terms catatonia, severe acute respiratory syndrome coronavirus 2, and COVID-19. Articles were limited to those published in the English language between 2020 and 2022. Forty-five articles that specifically studied catatonia associated with acute COVID-19 infection were screened.Results: Overall, 30% of patients with severe COVID-19 infection developed psychiatric symptoms. We found 41 cases of COVID-19 and catatonia, with clinical presentations that varied in onset, duration, and severity. One death was reported in a case of catatonia. Cases were reported in patients with and without a known psychiatric history. Lorazepam was successfully used, along with electroconvulsive therapy, antipsychotics, and other treatments.Conclusions: Greater recognition and treatment of catatonia in individuals with COVID-19 infection is warranted. Clinicians should be familiar with recognizing catatonia as a potential outcome of COVID-19 infection. Early detection and appropriate treatment are likely to lead to better outcomes.","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12788/acp.0109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Emerging literature supports the association between acute COVID-19 infection and neuropsychiatric complications. This article reviews the evidence for catatonia as a potential neuropsychiatric sequela of COVID-19 infection.

Methods: PubMed was searched using the terms catatonia, severe acute respiratory syndrome coronavirus 2, and COVID-19. Articles were limited to those published in the English language between 2020 and 2022. Forty-five articles that specifically studied catatonia associated with acute COVID-19 infection were screened.

Results: Overall, 30% of patients with severe COVID-19 infection developed psychiatric symptoms. We found 41 cases of COVID-19 and catatonia, with clinical presentations that varied in onset, duration, and severity. One death was reported in a case of catatonia. Cases were reported in patients with and without a known psychiatric history. Lorazepam was successfully used, along with electroconvulsive therapy, antipsychotics, and other treatments.

Conclusions: Greater recognition and treatment of catatonia in individuals with COVID-19 infection is warranted. Clinicians should be familiar with recognizing catatonia as a potential outcome of COVID-19 infection. Early detection and appropriate treatment are likely to lead to better outcomes.

查看原文本刊更多论文

COVID-19和紧张症:患病率、挑战、病理生理学和治疗。

背景:新出现的文献支持急性COVID-19感染与神经精神并发症之间的关联。本文回顾了紧张症作为COVID-19感染的潜在神经精神后遗症的证据。方法:使用紧张症、严重急性呼吸综合征冠状病毒2和COVID-19检索PubMed。文章仅限于在2020年至2022年期间用英语发表的文章。筛选了45篇专门研究与急性COVID-19感染相关的紧张症的文章。结果:总体而言，30%的重症COVID-19感染患者出现精神症状。我们发现41例COVID-19合并紧张症，其临床表现在发病、持续时间和严重程度上各不相同。据报道，有一人死于紧张症。病例报告的患者有或没有已知的精神病史。劳拉西泮与电休克疗法、抗精神病药物和其他治疗一起成功使用。结论:对COVID-19感染个体的紧张症有必要加强认识和治疗。临床医生应熟悉认识到紧张症是COVID-19感染的潜在结果。早期发现和适当治疗可能会带来更好的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Clinical Psychiatry PSYCHIATRY-

CiteScore

1.80

自引率

7.70%

发文量

审稿时长

>12 weeks

期刊介绍： The ANNALS publishes up-to-date information regarding the diagnosis and /or treatment of persons with mental disorders. Preferred manuscripts are those that report the results of controlled clinical trials, timely and thorough evidence-based reviews, letters to the editor, and case reports that present new appraisals of pertinent clinical topics.